China Universal Asset Management Company’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.22M Sell
119,272
-7,735
-6% -$229K 0.25% 71
2026
Q1
$3.52M Sell
127,007
-2,323
-2% -$59.7K 0.27% 69
2025
Q4
$2.81M Buy
129,330
+9,631
+8% +$190K 0.22% 82
2025
Q3
$1.81M Sell
119,699
-16,837
-12% -$208K 0.15% 122
2025
Q2
$1.54M Sell
136,536
-6,590
-5% -$71.4K 0.14% 130
2025
Q1
$1.44M Sell
143,126
-11,226
-7% -$121K 0.13% 141
2024
Q4
$1.83M Buy
154,352
+12,118
+9% +$143K 0.17% 111
2024
Q3
$1.64M Buy
142,234
+55,445
+64% +$631K 0.18% 108
2024
Q2
$917K Sell
86,789
-68,121
-44% -$746K 0.13% 109
2024
Q1
$1.63M Buy
154,910
+61,921
+67% +$668K 0.21% 92
2023
Q4
$1.04M Buy
92,989
+73,192
+370% +$713K 0.2% 105
2023
Q3
$231K Buy
19,797
+9,856
+99% +$111K 0.07% 140
2023
Q2
$100K Sell
9,941
-335
-3% -$3K 0.03% 154
2023
Q1
$75.8K Buy
10,276
+2,907
+39% +$23.9K 0.03% 140
2022
Q4
$58.9K Buy
+7,369
New +$41K 0.02% 133

Other funds holding ROIV

China Universal Asset Management Company's ROIV Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Roivant Sciences (ROIV) stake by 6.1% in Q2 2026, selling an estimated $229K and leaving 119,272 shares worth $4.22M. The position accounts for 0.25% of the portfolio, ranked #71.

China Universal Asset Management Company first reported a position in ROIV in Q4 2022 and has held it in 15 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • China Universal Asset Management Company held 119,272 shares of Roivant Sciences worth $4.22M as of Q2 2026.
  • China Universal Asset Management Company sold 7,735 Roivant Sciences shares in Q2 2026, an estimated $229K.
  • Roivant Sciences made up 0.25% of China Universal Asset Management Company's portfolio in Q2 2026, its #71 holding.
  • China Universal Asset Management Company first reported a position in Roivant Sciences in Q4 2022 and has held it in 15 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.